GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
16 Jan 2018 05:48 PM
RNS
Director/PDMR Shareholding
15 Jan 2018 05:59 PM
RNS
Director/PDMR Shareholding
15 Jan 2018 05:54 PM
RNS
Director/PDMR Shareholding
15 Jan 2018 05:34 PM
RNS
Director/PDMR Shareholding
15 Jan 2018 09:18 AM
RNS
Director/PDMR Shareholding
15 Jan 2018 09:04 AM
RNS
Director/PDMR Shareholding
11 Jan 2018 03:33 PM
RNS
Director/PDMR Shareholding
02 Jan 2018 02:00 PM
RNS
Director Shareholding
02 Jan 2018 01:54 PM
RNS
Total Voting Rights
21 Dec 2017 09:02 AM
RNS
FDA approval - on ICS/LABA combinations in asthma
18 Dec 2017 04:21 PM
RNS
Director/PDMR Shareholding
15 Dec 2017 07:00 AM
RNS
Transfer of Shares out of Treasury
12 Dec 2017 04:50 PM
RNS
Director/PDMR Shareholding
12 Dec 2017 04:16 PM
RNS
GSK gains US approval for Nucala to treat EGPA
12 Dec 2017 07:00 AM
RNS
Promising data for GSK2857916 at ASH meeting
06 Dec 2017 07:00 AM
RNS
New data - Shingrix in immune-compromised patients
01 Dec 2017 01:47 PM
RNS
Director/PDMR Shareholding
01 Dec 2017 01:44 PM
RNS
Director/PDMR Shareholding
01 Dec 2017 01:37 PM
RNS
Total Voting Rights
30 Nov 2017 07:00 AM
RNS
ViiV starts Phase 3 HIV prevention study in women
27 Nov 2017 02:03 PM
RNS
ViiV starts Phase 3 longacting HIV treatment study
23 Nov 2017 07:00 AM
RNS
GSK submit IMPACT data to support Trelegy Ellipta
22 Nov 2017 07:00 AM
RNS
ViiV Juluca approved in US as first 2-drug regimen
21 Nov 2017 02:21 PM
RNS
GSK publishes 2018 dividend dates
16 Nov 2017 07:00 AM
RNS
Trelegy Ellipta EU approval for treatment of COPD
10 Nov 2017 01:15 PM
RNS
Director/PDMR Shareholding
09 Nov 2017 05:00 PM
RNS
Block listing Interim Review
08 Nov 2017 02:00 PM
RNS
Directorate Change
08 Nov 2017 02:00 PM
RNS
Directorate Change
07 Nov 2017 03:01 PM
RNS
US regulatory application for mepolizumab in COPD
02 Nov 2017 07:35 AM
RNS
BCMA receives FDA Breakthrough Therapy Designation
01 Nov 2017 12:01 PM
RNS
Total Voting Rights
01 Nov 2017 11:01 AM
RNS
Superiority of Anoro Ellipta demonstrated for COPD
25 Oct 2017 05:46 PM
RNS
CDC ACIP makes recommendations for use of Shingrix
25 Oct 2017 03:21 PM
RNS
Director/PDMR Shareholding
25 Oct 2017 12:00 PM
RNS
3rd Quarter Results
23 Oct 2017 07:00 AM
RNS
GSK's Shingrix Receives US FDA Approval
20 Oct 2017 04:12 PM
RNS
Director/PDMR Shareholding
20 Oct 2017 04:08 PM
RNS
Director/PDMR Shareholding
16 Oct 2017 04:52 PM
RNS
Director/PDMR Shareholding
16 Oct 2017 04:42 PM
RNS
Director/PDMR Shareholding
16 Oct 2017 04:40 PM
RNS
Director/PDMR Shareholding
16 Oct 2017 04:40 PM
RNS
Director/PDMR Shareholding
16 Oct 2017 11:02 AM
RNS
Director/PDMR Shareholding
16 Oct 2017 10:57 AM
RNS
Director/PDMR Shareholding
13 Oct 2017 06:31 PM
RNS
GSK first approval of Shingrix in Canada
13 Oct 2017 04:25 PM
RNS
Director/PDMR Shareholding
13 Oct 2017 04:20 PM
RNS
Director/PDMR Shareholding
13 Oct 2017 11:53 AM
RNS
Director/PDMR Shareholding
11 Oct 2017 01:34 PM
RNS
Director/PDMR Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings